The innovation network Niedersachsen.next has honoured NanoDrug Delivery GmbH with the Lower Saxony Innovation Award 2024 in the ‘Knowledge and Technology Transfer’ category. The spin-off of the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT), the University Medical Center Göttingen (UMG) and the Karlsruhe Institute of Technology (KIT) received the award for its development of tiny transport systems for active medical ingredients.
‘We are developing innovative hybrid nanoparticles that bind active substances and transport them directly to the tumour cells. This means that normal body cells are less damaged,’ explains MBExC member Frauke Alves, research group leader at the MPI-NAT and UMG.
Link to the MPI-NAT press release (in German)